Pharmaceutical and Biological Products from the United States: Export Buying Guide

Buying pharmaceutical and biological products from the United States starts with a clear specification and an identified receiving market. Wigmore Trading can assess a sourcing or logistics brief and clarify what is needed for a written offer. A guide or product list is not confirmation of stock, supplier appointment or approval to trade a particular item.

Define the requirement before requesting prices

Begin with the exact product identity, intended authorised use, manufacturer, strength or concentration, pack size and destination. Finished medicines, active ingredients, research materials and biological products require different procurement routes. A broad customs category does not establish a product is suitable for ordinary wholesale distribution.

Use an authorised and traceable supply chain

Identify the licensed buyer, seller and importer responsible for the proposed transaction. Request batch evidence, storage history, remaining shelf life and the regulatory documents applicable to the product. Confirm that the receiving organisation can legally acquire and use the material. Research-use products should not be represented as approved clinical supplies, and no product in this guide is an open offer of controlled biological material.

Products to distinguish in your enquiry

The following are separate specification lines. Identify the exact product, grade or model and intended use rather than requesting an undifferentiated mixed shipment.

• Vaccines, blood, antisera, toxins and cultures
• Packaged Medicaments
• Hormones
• Nucleic Acids
• Special Pharmaceuticals
• Unpackaged Medicaments
• Micro-Organism Culture Preparations
• Vitamins
• Glands and Other Organs — lawful animal-derived materials only
• Peptones
• Animal Organs — lawful animal-derived materials only

References to glands and organs here mean lawful animal-derived materials for an identified, authorised application. Human organs and human tissues are not offered through this sourcing guide. Controlled biological materials require a separate specialist eligibility assessment; a keyword list is not an offer to supply them.

Qualify the logistics before committing to supply

Define temperature requirements, monitoring, packaging qualification, handling windows and responsibilities for excursions. Agree how authenticity and batch records will be checked before release. For medicines, obtain product-specific regulatory advice; an export certificate or US marketing status alone does not establish authorisation in the importing country. Enquiries are assessed individually through the appropriate specialist parties.

Compare the full commercial scope

Ask each supplier to quote the same specification, quantity, condition, packing basis and named delivery point. List the currency, quote validity, inspection scope, payment milestones and treatment of non-conforming goods. Request actual packed dimensions and gross weights before comparing freight options.

Keep product price separate from collection, export preparation, freight, insurance, destination charges, duties, storage and final delivery. Identify the party responsible for each stage. Do not pay for a shipment whose destination acceptance or essential technical specification is still unresolved.

Prepare a sourcing brief

Send the specification or catalogue reference, quantity and expected repeat demand, receiving location, required date and any supporting drawings or quality requirements. Say whether the enquiry is for an approved replacement, a new production input or resale. Ask for the manufacturer and origin to be identified; a source-country dispatch address alone does not establish origin.

For the official starting point, review FDA human drug exports and confirm the pathway for your exact product and destination with the responsible parties.

Use the US sourcing directory to compare related product guides, or the US commercial shipping guide when preparing cargo details.

Reviewed 1 November 2026. Gallery images illustrate procurement and logistics; they do not identify offered stock.